Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration

Fitting Linear Mixed-Effects Models Using <b>lme4</b>

Douglas M. Bates, Martin Mächler, Benjamin M. Bolker et al. · Journal of Statistical Software · 2015 · 85.6K citations · Full text

Business, Biostatistics, Optimization +15

Fast Stable Restricted Maximum Likelihood and Marginal Likelihood Estimation of Semiparametric Generalized Linear Models

Simon N. Wood · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 2010 · 7.6K citations · Full text

Business, Biostatistics, Method Validation +15

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text

Medicine, Ophthalmology, Surgery +12

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine · 2011 · 2.6K citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

Jeffrey S. Heier, David M. Brown, Victor Chong et al. · Ophthalmology · 2012 · 2.5K citations

Medicine, Ophthalmology, Vision Science +16